Evidence map›Paper›PMID 34770146›Full record

ArticleInternational journal of environmental research and public health2021

Right Ventricular Endocardial Mapping and a Potential Arrhythmogenic Substrate in Cardiac Amyloidosis-Role of ICD.

Aleksandra Liżewska-Springer, Tomasz Królak, Karolina Dorniak, Maciej Kempa, Alicja Dąbrowska-Kugacka, Grzegorz Sławiński, Ewa Lewicka

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aleksandra Liżewska-SpringerDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-952 Gdansk, Poland.
Tomasz KrólakDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-952 Gdansk, Poland.
Karolina DorniakDepartment of Nonivasive Cardiac Diagnostics, Medical University of Gdansk, 80-952 Gdansk, Poland.ORCID 0000-0002-5226-8311
Maciej KempaDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-952 Gdansk, Poland.
Alicja Dąbrowska-KugackaDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-952 Gdansk, Poland.ORCID 0000-0002-5546-7818
Grzegorz SławińskiDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-952 Gdansk, Poland.ORCID 0000-0002-1974-6393
Ewa LewickaDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-952 Gdansk, Poland.ORCID 0000-0002-0162-2659

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with cardiac amyloidosis (CA) have an increased risk of sudden cardiac death. (SCD). However, the role of an implantable cardioverter-defibrillator in the primary prevention of SCD in this group of patients is still controversial. We present a case with CA with recurrent syncope and non-sustained ventricular tachycardia. In order to further stratify the risk of SCD, an electrophysiological study with endocardial electroanatomic voltage mapping was performed prior to the ICD placement.

Indexed as

AmyloidosisArrhythmogenic Right Ventricular DysplasiaArrhythmias, CardiacDeath, Sudden, CardiacHumansPrimary Preventioncardiac amyloidosiselectrophysiological study mappingimplantable cardioverter-defibrillatorsudden cardiac death

Identifiers

PMID34770146
PMCPMC8583432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.